The good, the bad and the ugly about the Foundation for a Smoke-Free World

Similar documents
Heat-not-Burn Products: Scientific Assessment of Risk Reduction

Joanna Cohen, PhD Institute for Global Tobacco Control Johns Hopkins Bloomberg School of Public Health

The importance of offering adult smokers a portfolio of potentially less harmful products

Smoking Harm Reduction: If Not Now When?

PMI Representations to TPSAC about Marketing of iqos in the U.S.

Global Goals Yearbook

WHO Framework Convention on Tobacco Control

How to Regulate E-Cigarettes? Are we asking the right questions?

Assessment of the Tobacco Heating System (THS) 2.2, A Candidate Modified Risk Tobacco Product: From Concept to Early Clinical Data

AN UPDATE ON FDA S COMPREHENSIVE PLAN ON TOBACCO AND NICOTINE

The State of Smoking 2018 Global Survey Findings and Insights. Monday, March 19, 2018

Sustainability Report 2017

Tobacco Heating System 2.2, A Candidate Modified Risk Tobacco Product: Cardiovascular Disease Risk Assessment

Investor Day Lausanne, September 27, 2018

REPORT OF THE BOARD OF TRUSTEES. Subject: Annual Update on Activities and Progress in Tobacco Control: March 2017 through February 2018

Strengthening National Tobacco Control in Jordan

THE STATE OF TOBACCO CONTROL LAW & POLICY THE NATIONAL LANDSCAPE OF FEDERAL, STATE AND LOCAL REGULATION

American Vaping Association

Vontobel Viewpoints FDA New Direction on Tobacco Our Take

SNUS ON THE LOOSE: Big Tobacco s s latest attempt to make nicotine more attractive

Tobacco-Control Policy Workshop:

Best if Clearly LAbeled. How the Consumer Packaged Goods Industry is Reducing Confusion and Food Waste

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association

RESPONSE FROM ALTRIA:

Art Alternatives to tobacco growing

The State of Smoking 2018 Global Survey Findings and Insights. Monday, March 19, 2018

JTI Switzerland. JTI Schweiz 3

Partnering Against Corruption Initiative (PACI) Sao Paulo, Brazil. World Economic Forum. 21 st June, 2006

Who is Targeting You? The Tobacco Industry Those who want to profit from your smoking

Report to the GAVI Alliance Board 7-8 July 2011

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

Get the Facts: Minnesota s 2013 Tobacco Tax Increase is Improving Health

Swiss National Strategy on Open Access

Submission by the Federation of European Cancer Societies to the Public Hearings on the WHO Framework Convention on Tobacco Control

Eurasian Harm Reduction Association (EHRA) Strategic Framework

Building Capacity for Tobacco Dependence Treatment in Japan. Request for Proposals (RFP) - Background and Rationale

TOBACCO CONTROL & THE SUSTAINABLE DEVELOPMENT GOALS

Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re

Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK

Prepare for tobacco industry interference

RTI International; 2 Wake Forest University School of Medicine; 3

Access to clinical trial information and the stockpiling of Tamiflu. Department of Health

Modified Risk Tobacco Product Applications A Succinct ENDS Industry Perspective

TFI WHO 20 Avenue Appia 1211 Geneva 27, Switzerland. Gentlemen:

- Decree nº (January 2 nd, 2006) Promulgates the Framework Convention on Tobacco Control

Fumo, riduzione del danno e rischio oncologico

Use of Light, Mild, Low, or Similar Descriptors in the Label, Labeling, or Advertising of Tobacco Products

Ambitious Futures 2020 Strategy

Homeopathy: the need for robust evidence to inform consumer choice

Overall Assessment: Good level of support for target although there were some concerns on achievability.

Communication on Progress 2016 United Nations Global Compact

IC Chapter 4. Indiana Tobacco Use Prevention and Cessation Trust Fund

Eurasian Harm Reduction Association (EHRA) Strategic Framework

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis

The facts are in: Minnesota's 2013 tobacco tax increase is improving health

Asia Illicit Tobacco Indicator 2016: Pakistan. Prepared by Oxford Economics November 2017

Texas Bill to Regulate Vapor Products. Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes

Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center, and Dean, Vanderbilt University School of Medicine.

Investor Day Lausanne, September 27, 2018

Key findings from a national survey of 1,000 registered voters, conducted February 2-5, Project # 15054

Global Best Practices in Tobacco Control

No one should be at risk of poor health because of their social and economic situations.

ELECTIONS APPLICATION FORM WPHNA Executive Committee

Estimating the volume of Contraband Sales of Tobacco in Canada:

UN Agencies strategic approach to Articles 17 and 18 of the WHO FCTC. Geneva, 17 November 2017

Reducing Liability by Hiring The Right Employ lo ee What Type of Screenings to Conduct Why Conduct Background Checks?

Using Science to Inform Public Policy: A Case Study on Tobacco Retail Regulation in Buffalo, NY.

Harm reduction, the profit motive and tobacco industry tactics Why caution is necessary

Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21

Policy making at the American Chemical Society (ACS) - developing a statement on scientific integrity

Building a Digital Home to Provide Patient Support, Education and Clinical Trial Awareness

Re: Docket No. FDA-2009-N-0294 Regulation of Tobacco Products; Request for Comments

Anti-smoking: The battle continues

An Analysis of Lobbying Activity on Tobacco Issues in the Wisconsin Legislature

Estimating the economic value of reducing smoking rates in Canada to 18% and the cost of failing to achieve the 12% goal.

The Inclusion of Seasonal Influenza Viruses and Genetic Sequence Data (GSD) in the Context of the Pandemic Influenza Preparedness (PIP) Framework

GuideStar Impact Call

UTAH VOTERS FAVOR RAISING THE LEGAL AGE FOR THE SALE OF TOBACCO TO AGE 21.

INTERNATIONAL INITIATIVE FOR ACTION AND RESEARCH ON TOBACCO

EVMS Authorship Guidelines

FDA S CENTER FOR TOBACCO PRODUCTS: AN UPDATE ON REGULATORY ACTIVITIES AND PRIORITIES

Legalization of Cannabis: The Way Forward

Page 1 of 20. Results of national survey on perception of plain packaging on cigarettes and the government consultation August 2016

U.S. House of Representatives U.S. Senate. U.S. House of Representatives U.S. Senate

TOBACCO DEPENDENCE MANAGEMENT AND TOBACCO CONTROL

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update

INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY

Funding Chapter Programs. San Antonio 2001 Chapter Chairs Workshop

Moorfields Eye Charity Strategy People's sight matters

A proposal for managing tobacco supply reduction in Ontario 2005 to Neil Collishaw Physicians for a Smoke-Free Canada April 2005

Show the truth. Picture warnings save lives. WORLD NO TOBACCO DAY 31 MAY 2009

NATIONAL TOBACCO REFORM INITIATIVE

Logic models to enhance program performance

The gateway theory. Pr Jean-François ETTER PhD (political science) E-cigarette Summit London, November 17, Competing interests: none

Multi-Country Opinion Research Survey TOPLINE RESULTS GLOBAL AVERAGE

JOINT TESTIMONY. Homeless Services United Catherine Trapani Executive Director, HSU

Social Studies Skills and Methods Analyzing the Credibility of Sources

The Independent British Vape Trade Association (IBVTA) welcomes the opportunity to respond to this consultation.

Tobacco- Free Funding Policies Part Two: Policy Steps

Transcription:

The good, the bad and the ugly about the Foundation for a Smoke-Free World Pr. Jean-François ETTER, PhD E-cigarette Summit, London November 17, 2017 No competing interests I talked to Derek Yach in preparing this presentation I thank those who read preliminary versions and provided ideas

Context Disruptive technologies Rapid market transformation (IQOS=14% of all tobacco sold in Japan) New strategy of Philip Morris International (PMI): - product diversification, non-combustible products, - stated goal to eliminate combustion New products increase legal liabilty for Big Tobacco: cigarettes = defective Highly emotional debate

Foundation for a Smoke-Free World, Inc. (FSFW) Foundation was first announced by PMI CEO A. Calantzopoulos Launched in Sept 2017 at a tobacco-industry sponsored event (GTNF, NY) Funded by PMI, $1 billion over 12 years, = 80 million / year = 1% of PMI s marketing budget Derek Yach: led the development of FCTC at WHO (1990s-2000s) Focus on harm reduction, new non-combustible products Aligns with PMI industrial strategy : product diversification Defense in product liability claims : they show they do all they can

Foundation for a Smoke-Free World, Inc. (FSFW) Bylaws, governance, US IRS registration documents, and agreement with PMI designed to prevent PMI influence Stated willingness of FSFW to act towards independence + transparency Objectives: - support research - provide directions and recommendations to reduce smoking - monitor industry activity - verify progress on elimination of smoking - help farmers find alternative income - create next generation of leaders and researchers

Reactions Many negative reactions, as could be expected Positive reactions too, according to FSFW - many researchers, institutions want to collaborate - provide ideas for research - requests for employment

Criticism 1) FSFW not independent from PMI PMI provided initial funding Historical record of scientific misconduct from PMI, other PMI s scientific initiatives used to undermine tobacco control : - Whitecoat Project, INBIFO FSFW is seen as part of PMI s strategy to create doubt + controversies PMI may benefit from research results Director was selected by PMI and was paid by PMI (not anymore), and he led the process of selecting the board of directors Disingenuous: PMI should stop undermining anti-smoking laws and suing Govmt

Criticism 2) Reject harm reduction + new products Some critics of FSFW reject harm reduction as a tobacco control strategy They reject new reduced-risk products, in particular if sold by tobacco industry Cessation only Use traditional strategies instead (MPOWER) e.g. WHO FCTC Secretariat

Is there anything good about FSFW? Money = New talent, new countries Ambitious, well-funded for 12 years Currently, too little research capacity, too little money, too few researchers More research is needed on harm reduction and reduced-risk products FSFW intends to fill these gaps FSFW may attract new talent, researchers not yet involved in tobacco = new methods, new perspectives, fewer pre-conceptions Fund research in countries where there is currently little research More diversity More global

Anything good? Potential for quality More money = - better equipment, - «definitive» studies in large samples, - replication studies FSFW grant applications will be competitive + peer-reviewed, all studies will be published, all original data will be made available (but will studies and analyses be pre-registered?)

Less tainted than research done directly by PMI PMI, BAT invest billions in R & D Broad range of studies Research done by PMI is already used by Gov agencies, policy makers e.g. FDA application to register IQOS as a reduced-risk product FDA decision will be based almost entirely on PMI research FSFW-sponsored research may be less tainted than research done directly by PMI

Anything good? Harm reduction, new products WHO, FCTC COP are very negative about harm reduction, new products Some countries follow WHO lead and are reluctant to fund research FSFW = more research on harm reduction, on new products, However, USA and other countries fund research on reduced-risk products and new strategies

Should we participate, apply for grants or boycott FSFW? For boycott: PMI sells deadly products, engaged in scientific misconduct, opposes FCTC PMI may use FSFW output to challenge anti-smoking policies FSFW = public relation gains for PMI : «corporate responsibility» Any study funded by FSFW could be clouded by the suspicion of bias Avoid association with PMI and conflicts of interest Risk for career, reputation Journals: Will journals that don t publish tobacco industry-funded research publish research funded by FSFW? (BMJ, Thorax, Heart, Tobacco Control)

Against boycott Censorship approach Against basic scientific principles of open discussion between peers Discuss with all parties, in particular if you don t agree with them Boycott based on ideology rather than scientific principles Possible public relations benefits for PMI if public health rejects FSFW The FSWF is not PMI

If researchers don t apply or public health does not participate, then Wasted money $1 billion It may take longer to prove the effects of - reduced-risk products - harm reduction strategies Narrower range of research will be funded, in fewer countries, less diversity Most research on new products will be done by the industry itself

What more can FSFW do to be considered independent? Fulfill criteria for the acceptability of tobacco industry-funded research: - Transparency and independence - Governance, directorate - Protection against conflicts of interest - etc. J. Cohen, M. Zeller et al. Tobacco Control. 2009;18:228 FSFW says it aims at meeting these criteria Use this framework to: - dialogue with FSFW, - hold FSFW accountable

What more can FSFW do to be considered independent? Letter from Clive Bates and others to Derek Yach, November 16 : Donation should be irrevocable One-off payment, like an endowment Or if 12x, it should be no possible for PMI to withhold annual payments No repeated funding before after year 12 Independent board of directors, modest honoraria Find other funding sources Accept the scrutiny of an ad hoc external oversight group For some opponents, FSFW may never be acceptable whatever it does to prove its independence

What can researchers + public health people do? Be aware that emotions can cloud rationality Public health: Dialogue with FSFW to help them fulfill criteria for independence Participate in external oversight group Apply extensive scrutiny Hold FSFW accountable for its promises Individual researchers may want to participate only after : FSFW s independence is more widely demonstrated Careful assessment of risks for career, reputation

Conclusions FSFW is a work in progress: not yet at the point where it can be considered independent, credible and acceptable Clarity needed on funding, governance, directorate, external oversight FSFW may have the potential to be useful if its independence from PMI can be demonstrated